ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,037.88
0.72%
Dow Jones
44,556.04
0.30%
US Dollar vs MXN
20.51389
-0.01%
Brent Oil
75.35
-0.78%
Bitcoin
97,944.93
0.09%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE

  6. Jpmorgan China Growth & Income Plc (JCGI) Cotización

Jpmorgan China Growth & Income Plc

Jpmorgan China Growth & Income Plc (JCGI)

LSE
226.00
-7.00
( -3.00% )
Actualizado: 04:48:56
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
226.00
Postura de Compra
227.50
Postura de Venta
231.00
Volume Operado de la Acción
46,917
226.00 Rango del Día 229.50
182.60 Rango de 52 semanas 279.00
Capitalización de Mercado [m]
188.038M
Precio Anterior
233.00
Precio de Apertura
229.50
Hora
31
@
228.745
(O)
Última hora de negociación
05:00:50
Volumen financiero
107,102p
Precio Promedio Ponderado
228.2795
Volumen promedio (3 m)
182,001
Acciones en circulación
83,202,465
Rendimiento del Dividendo
4.83%
Ratio Precio/Utilidad
29.91
Beneficio por acción (BPA)
0.08
turnover
10.05M
Beneficio neto
6.32M

Acerca de Jpmorgan China Growth & Income Plc

Sector
Trust,ex Ed,religious,charty
Industria
Investment Trusts Div'd
Sitio web
www.jpmchinagrowthandincome.co.uk
Sede
London, Gbr
Fundado
1993
Jpmorgan China Growth & Income Plc is listed in the Trust,ex Ed,religious,charty sector of the London Stock Exchange with ticker JCGI. The last closing price for Jpmorgan China Growth & ... was 233p. Over the last year, Jpmorgan China Growth & ... shares have traded in a share price range of 182.60p to 279.00p.

Jpmorgan China Growth & ... currently has 83,202,465 shares in issue. The market capitalisation of Jpmorgan China Growth & ... is £193.86 million. Jpmorgan China Growth & ... has a price to earnings ratio (PE ratio) of 29.91.

JCGI Últimas noticias

Más noticias

JPMorgan China Growth & Income PLC Net Asset Value(s)

JPMorgan China Growth & Income PLC 05 February 2025   JPMORGAN CHINA GROWTH & INCOME PLC  (the 'Company')   Legal Entity Identifier: 549300S8M91P5FYONY25 THE COMPANY ANNOUNCES THE...

1 hora hace
RNS Regulatory News

JPMorgan China Growth & Income PLC Net Asset Value(s)

JPMorgan China Growth & Income PLC 04 February 2025   JPMORGAN CHINA GROWTH & INCOME PLC  (the 'Company')   Legal Entity Identifier: 549300S8M91P5FYONY25 THE COMPANY ANNOUNCES THE...

04 Febrero 2025
RNS Regulatory News

JPMorgan China Growth & Income PLC Gearing Announcement

JPMorgan China Growth & Income PLC 03 February 2025   JPMORGAN CHINA GROWTH & INCOME PLC (the 'Company')   Legal Entity Identifier: 549300S8M91P5FYONY25 THE COMPANY ANNOUNCES THE...

03 Febrero 2025
RNS Regulatory News

JPMorgan China Growth & Income PLC Net Asset Value(s)

JPMorgan China Growth & Income PLC 03 February 2025   JPMORGAN CHINA GROWTH & INCOME PLC  (the 'Company')   Legal Entity Identifier: 549300S8M91P5FYONY25 THE COMPANY ANNOUNCES THE...

03 Febrero 2025
RNS Regulatory News

JPMorgan China Growth & Income PLC Net Asset Value(s)

JPMorgan China Growth & Income PLC 31 January 2025   JPMORGAN CHINA GROWTH & INCOME PLC  (the 'Company')   Legal Entity Identifier: 549300S8M91P5FYONY25 THE COMPANY ANNOUNCES THE...

31 Enero 2025
RNS Regulatory News

JPMorgan China Growth & Income PLC Net Asset Value(s)

JPMorgan China Growth & Income PLC 30 January 2025   JPMORGAN CHINA GROWTH & INCOME PLC  (the 'Company')   Legal Entity Identifier: 549300S8M91P5FYONY25 THE COMPANY ANNOUNCES THE...

30 Enero 2025
RNS Regulatory News

JPMorgan China Growth & Income PLC Net Asset Value(s)

JPMorgan China Growth & Income PLC 29 January 2025   JPMORGAN CHINA GROWTH & INCOME PLC  (the 'Company')   Legal Entity Identifier: 549300S8M91P5FYONY25 THE COMPANY ANNOUNCES THE...

29 Enero 2025
RNS Regulatory News

JPMorgan China Growth & Income PLC Net Asset Value(s)

JPMorgan China Growth & Income PLC 28 January 2025   JPMORGAN CHINA GROWTH & INCOME PLC  (the 'Company')   Legal Entity Identifier: 549300S8M91P5FYONY25 THE COMPANY ANNOUNCES THE...

28 Enero 2025
RNS Regulatory News

JPMorgan China Growth & Income PLC Gearing announcement

JPMorgan China Growth & Income PLC 27 January 2025   JPMORGAN CHINA GROWTH & INCOME PLC (the 'Company')   Legal Entity Identifier: 549300S8M91P5FYONY25 THE COMPANY ANNOUNCES THE...

27 Enero 2025
RNS Regulatory News

JPMorgan China Growth & Income PLC Net Asset Value(s)

JPMorgan China Growth & Income PLC 27 January 2025   JPMORGAN CHINA GROWTH & INCOME PLC  (the 'Company')   Legal Entity Identifier: 549300S8M91P5FYONY25 THE COMPANY ANNOUNCES THE...

27 Enero 2025
RNS Regulatory News
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-1-0.440528634361227237225.5184970231.31645544DE
410.54.87238979118215.5237210236902223.57174677DE
12-0.5-0.220750551876226.5238.5210182001223.48786687DE
2635.818.8222923239190.2279182.6263349224.4228066DE
5231.816.3748712667194.2279182.6238640222.46293339DE
156-219.5-49.2704826038445.5464182.6214314282.04314271DE
260-129-36.338028169355872182.6257714439.02646865DE

JCGI - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Jpmorgan China Growth & ...?
El precio actual de las acciones de Jpmorgan China Growth & ... es 226.00p
¿Cuántas acciones de Jpmorgan China Growth & ... están en circulación?
Jpmorgan China Growth & ... tiene 83,202,465 acciones en circulación
¿Cuál es la capitalización de mercado de Jpmorgan China Growth & ...?
La capitalización de mercado de Jpmorgan China Growth & ... es GBP 193.86M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Jpmorgan China Growth & ...?
Jpmorgan China Growth & ... ha negociado en un rango de 182.60p a 279.00p durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Jpmorgan China Growth & ...?
El ratio precio/beneficio de Jpmorgan China Growth & ... es 29.91
¿Cuál es el ratio de efectivo a ventas de Jpmorgan China Growth & ...?
El ratio de efectivo a ventas de Jpmorgan China Growth & ... es 18.79
¿Cuál es la moneda de reporte de Jpmorgan China Growth & ...?
Jpmorgan China Growth & ... presenta sus resultados financieros en GBP
¿Cuál es el último ingresos anual de Jpmorgan China Growth & ...?
El último ingresos anual de Jpmorgan China Growth & ... es GBP 10.05M
¿Cuál es el último beneficio anual de Jpmorgan China Growth & ...?
El último beneficio anual de Jpmorgan China Growth & ... es GBP 6.32M
¿Cuál es la dirección registrada de Jpmorgan China Growth & ...?
La dirección registrada de Jpmorgan China Growth & ... es 60 VICTORIA EMBANKMENT, LONDON, EC4Y 0JP
¿Cuál es la dirección del sitio web de Jpmorgan China Growth & ...?
La dirección del sitio web de Jpmorgan China Growth & ... es www.jpmchinagrowthandincome.co.uk
¿En qué sector industrial opera Jpmorgan China Growth & ...?
Jpmorgan China Growth & ... opera en el sector INVESTMENT TRUSTS DIV'D

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
XSGXeros Technology Group Plc
0.725p
(38.10%)
14.44M
GFINGfinity Plc
0.075p
(36.36%)
21.36M
SYMESupply@me Capital Plc
0.0034p
(23.64%)
99.55M
IKAIlika Plc
33.00p
(22.22%)
563.32k
MACMarechale Capital Plc
3.70p
(19.35%)
8.6M
KRPZKropz Plc
0.85p
(-26.09%)
128.73k
TRCThe Revel Collective Plc
0.175p
(-22.22%)
4.15M
PRDPredator Oil & Gas Holdings Plc
4.25p
(-22.02%)
20.33M
SCGLSealand Capital Galaxy Limited
4.25p
(-21.30%)
3.88M
WBIWoodbois Limited
0.065p
(-21.21%)
269.51M
NTVONativo Resources Plc
0.0017p
(0.00%)
480.21M
WBIWoodbois Limited
0.065p
(-21.21%)
269.51M
OBDOxford Biodynamics Plc
0.575p
(15.00%)
266.81M
MSMNMosman Oil And Gas Limited
0.041p
(-5.75%)
199.86M
DKEDukemount Capital Plc
0.045p
(-1.10%)
155.66M

Discusión

Ver feed completo
floblu14 floblu14 4 minutos hace
Barbara Fiacco is a lawyer representing Enanta, correct? CORRECT!
She has represented leading pharmaceutical and life sciences clients in significant patent infringement lawsuits that have resulted in summary judgment or other favorable outcomes for her clients.

Also,
D
ENTA
Capt Caveman Capt Caveman 6 minutos hace
short volume percentage
10.61% 2-4-25

OTCShortReport.com

DBMM
DBMM
The ELTP King The ELTP King 6 minutos hace
********** NEW! **********

LOXAPINE SUCCINATE
ANDA #076868 SUPPL-12
ELITE LABS INC
Status: Labeling Approval

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076868
ELTP
TechandBio TechandBio 7 minutos hace
Should see the 60's! core holding in my IRA was $7.00 not that long ago need the foresight to really hit these home runs!
AKRO
jordan95 jordan95 9 minutos hace
They have a new post on x about this deal they're announcing I left a comment about the dilution happening
ASII
10thMountain 10thMountain 10 minutos hace
It needs a good catalyst. One with substance, and no fluff
FDCT
shadolane shadolane 11 minutos hace
Thank you for your reply.
AMRN
KenKong KenKong 12 minutos hace
style="caret-color: rgb(34, 34, 34); color: rgba(34, 34, 34, 1); font-family: Roboto, "Helvetica Neue", Helvetica, Arial, sans-serif; background-color: rgba(255, 255, 255, 1)""Critical projects in Alaska like Ambler Road and Pebble Mine and oil and gas exploration in ANWR which are held up by radica
NAK
rolvram rolvram 14 minutos hace
Deepseek is lying and used 5k H-100
NVDA
TechandBio TechandBio 14 minutos hace
Fat synthesizer oral drug best in class SGMT Break through designation can apply for approval with Phase 3 after 1 year if the data follows their phase2b readout. Tam for Mash and Obesity will be over a quarter trillion in the coming years.


Pediatric Nash for SGMT i Pediatr
AKRO MDGL SGMT
Chiron Chiron 16 minutos hace
The exciting deal should see this hit .0006 and then collapse to .0003
ASII
PennMilitia PennMilitia 16 minutos hace
Fannie-Mae made 44m dollars-per-day / 3rd QTR

Hope those numbers keep coming in for the 4th QTR 2024.
FNMA
TechandBio TechandBio 17 minutos hace
Should double from here next 12-24 months. playing some options pretty far out.

$SMMT
SMMT
budfoxfun budfoxfun 17 minutos hace
Tony Raynor Teams Up With Fishing Legend Jimmy Houston to Showcase Organic Solutions for Food Security https://finance.yahoo.com/news/sustainable-green-team-unveils-revolutionary-165500864.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr
SGTM
budfoxfun budfoxfun 18 minutos hace
Our patented technologies incorporates cutting-edge technologies like Biological Hydrosynthesis and Ecological Stem Cell Technology. It addresses key environmental issues on a global scale, including safe organic residue handling, viable topsoil replacement, and the addition of a third water source.
SGTM
theorysuit theorysuit 19 minutos hace
Oh blame the mhra.....this is the company mantra. Blame anyone but ourselves for this horrible execution. Update shareholders and stop blaming others and have some accountability for once in their pathetic existence.
NWBO
ksquared ksquared 19 minutos hace
This does NOT give me the warm and fuzzies...
Trump says ‘US will take over the Gaza Strip’ — after relocating ‘all’ Palestinians
By Steven Nelson Published Feb. 4, 2025 Updated Feb. 4, 2025, 8:03 p.m. ET
https://nypost.com/2025/02/04/us-news/trump-say
TechandBio TechandBio 22 minutos hace
Re entered a core position the high teens in January im my IRA account.

$PLSE
PLSE
Teddytropics Teddytropics 24 minutos hace
Hey that's too much DD for this guy..

It ruins his script..
CNNA
TheRealMrPirate TheRealMrPirate 24 minutos hace
Can you also jump in the lake to prove your love for Bioamber and also KKR
For KKR I would love to jump in a lake, KKR is still in business and very profitable.
You should think of purchasing some KKR shares, I hear they're very valuable - https://finance.yahoo.com/quote/KKR/.
U
dheminger dheminger 25 minutos hace
That would be a start. They definitely could uplist to OTCQB from there. 
ATWT
TechandBio TechandBio 27 minutos hace
The company doesn't care about retail investors Dilly making close to 2 Million a year the last hire Christos Richards was suspect.
there DEI programs within the company is not ideal have to be patient here. More of a 2026 and beyond narrative.

$CDXS
CDXS
theorysuit theorysuit 27 minutos hace
Company doesnt provide updates so you go to mhra. And the mhra said it is progress. Pathetic. Sounds like nwbo still needs to provide info. To be expected from the POS company.
NWBO

Su Consulta Reciente

LSE
JCGI
Jpmorgan China Growth & ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios